Key result
Patients with valvular heart disease had significantly elevated rates of cerebrovascular events (SMR 3.2; 95% CI 2.6-3.8) and death (SMR 2.5; 95% CI 2.2-2.7) compared to expected numbers.
Why the study?
What are the rates and predictors of cerebrovascular events and death among patients with valvular heart disease?
Cohort (n=793)
No
What are the rates and predictors of cerebrovascular events and death among patients with valvular heart disease?
Effect estimate: SMR 3.2 (cerebrovascular events), SMR 2.5 (death) (95% CI 2.6-3.8, 2.2-2.7)
Patients with valvular heart disease face a significantly increased risk of cerebrovascular events and death compared to the general population, with severe aortic stenosis and atrial fibrillation acting as key predictors.
No takes yet. Share an insight, caveat, or question.
May warrant closer cerebrovascular monitoring in valvular heart disease; leaves open whether targeted interventions reduce excess events.
Petty et al. (2000) conducted a cohort in Valvular heart disease (n=793). Valvular heart disease vs. Expected numbers (general population) was evaluated on Cerebrovascular events and death (SMR 3.2 (cerebrovascular events), SMR 2.5 (death), 95% CI 2.6-3.8, 2.2-2.7). Patients with valvular heart disease had significantly elevated rates of cerebrovascular events (SMR 3.2; 95% CI 2.6-3.8) and death (SMR 2.5; 95% CI 2.2-2.7) compared to expected numbers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: